Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 8—August 2025

Research Letter

Severe Fever with Thrombocytopenia Syndrome Acquired through Dog Bite, South Korea

Uh Jin Kim1, Hae Seong Jeong1, Keon Kim1, Ahrang Lee, Minji Kim, Sarah Kim, Sung Un Shin, Seung-Ji Kang, Sook In Jung, Hyungjun Kwak, Woong-bin Ro, Choon-Mee Kim, Dong-Min Kim2, and Kyung-Hwa Park2Comments to Author 
Author affiliation: Chonnam National University Hospital, Gwangju, South Korea (U.J. Kim, H.S. Jeong, A. Lee, M. Kim, S. Kim, S.U. Shin, S.-J. Kang, S.I. Jung, K.-H. Park); Chonnam National University Medical School, Gwangju (U.J. Kim, S.-J. Kang, S.I. Jung, K.-H. Park); Chonnam National University College of Veterinary Medicine, Gwangju (K. Kim, W. Ro); Gwangsan-gu Public Health Center, Gwangju (H. Kwak); Chosun University College of Medicine (C.-M. Kim, D.-M. Kim); Chosun University Hospital, Gwangju (D.-M. Kim)

Main Article

Table

Characteristics of samples infected with severe fever with thrombocytopenia syndrome virus, South Korea*

Source Day Specimen Nested PCR
 qPCR
 IFA†
S seg, 346 bp M seg, 540 bp L seg, 860 bp S seg, 71 bp IgG IgM
Human
 HD 2
 Blood
 Positive
 Positive
 Positive
26.76
<1:32
 <1:32
Dog HD 0 Blood Weak positive Positive Positive 32.99 ND ND
HD 2 Blood Negative Negative Negative 38.32 >1:1,024 ND
HD 4 Urine Negative Negative Negative 32.18 1:32 ND
HD 4 Saliva Negative Negative Negative 36.44 ND ND

*HD, hospital day. IFA, indirect immunofluorescence assay; L, large; M, medium; ND, not done; qPCR, quantitative PCR; S, small; seg, segment. †IFA was performed on serum samples for both the patient and the dog. For the dog, urine and saliva specimens collected on HD 4 (July 6) were also tested in an exploratory manner to assess potential antibody presence in nonserum body fluids.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

Page created: July 09, 2025
Page updated: July 18, 2025
Page reviewed: July 18, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external